Whittier, Calif.-based non-profit healthcare provider PIH
Health revealed that it has chosen
Allscripts Healthcare Solutions
) Sunrise suite as the electronic health record (EHR) system for
its recently acquired 199-bed care facility in Downey, renamed as
PIH Health Hospital - Downey.
ADVAXIS INC (ADXS): Free Stock Analysis
BOSTON SCIENTIF (BSX): Free Stock Analysis
ALLSCRIPTS HLTH (MDRX): Free Stock Analysis
TRINITY BIOTECH (TRIB): Free Stock Analysis
To read this article on Zacks.com click here.
The reason behind choosing Allscripts Healthcare Solutions'
Sunrise suite is its integrated, interoperable and innovative
care coordination, open platform and population health
PIH Health operates two hospitals, a number of outpatient medical
offices, a multi-specialty medical group, and home health and
hospice care. It looks after more than 1.5 million people
residing in the Los Angeles and Orange County, and San Gabriel
In order to extend relationship with MDRX, PIH Health has also
added licenses for additional products and services and extended
its enterprise-wide hosting and managed services contract with
Allscripts till 2020.
As part of the deal, PIH Health will deploy most of the
Allscripts Acute and Ambulatory product suite including Sunrise,
Enterprise, dbMotion, FollowMyHealth patient portal and Care
Management solutions. The deal is expected to generate $120
million of incremental revenues to Allscripts Healthcare
Solutions over its tenure.
Apart from PIH Health, Appalachian Regional Healthcare System in
the High Country and South Australian government's health
department, SA Health, have also implemented Allscripts
Healthcare Solutions' Sunrise Clinical Manager (SCM) EHR system
in the recent past.
Allscripts Healthcare Solutions posted a significant fall in
adjusted earnings to $2.2 million or a penny per share in the
second quarter of 2013 from $23.1 million or 13 cents in the
comparable quarter of 2012. With this, earnings also missed the
Zacks Consensus Estimate of 7 cents for the quarter.
Revenues in the quarter ebbed 6.8% to $344.8 million, again
missing the Zacks Consensus Estimate of $358 million. The
decrease can be attributable to lower revenues generated from all
the operating segments.
Currently, MDRX retains a Zacks Rank #3 (Hold). While we remain
on the sidelines about the company, there are no other stocks in
the medical information systems industry that worth a look.
However, we can consider stocks from the medical products
industry such as
Trinity Biotech plc
) with a Zacks Rank #1 (Strong Buy), and
Boston Scientific Corp.
), both with a Zacks Rank #2 (Buy).